Company Cerulean Pharma Inc Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Women's Health
100.0
%
| 10 | 100.0 % | 3 | 100.0 % | -71.92% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 3 | 100.0 % | -71.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Christine Mauck
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
David Friend
CTO | Chief Tech/Sci/R&D Officer | - | 18-06-05 |
Mark Walters
COO | Chief Operating Officer | 69 | 14-12-31 |
Comptroller/Controller/Auditor | 47 | 18-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 | |
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Jessica Grossman
BRD | Director/Board Member | 52 | 18-04-08 |
Susan Kelley
BRD | Director/Board Member | 69 | 14-09-30 |
Gregory Matz
BRD | Director/Board Member | 64 | 18-09-12 |
Director/Board Member | 40 | 21-04-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 100,581,900 | 98,919,352 ( 98.35 %) | 0 | 98.35 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |